Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder that affects the carriers of premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. Common features of FXTAS include progressive intention tremor, gait ataxia, Parkinsonism, and cognitive decline. The neuropathological hallmarks of FXTAS include ubiquitin-positive intranuclear inclusions throughout brain and marked dropout of Purkinje neurons in cerebellum. The long-term goal of this project is to understand the molecular pathogenesis of FXTAS, and develop effective therapeutic interventions for FXTAS. Several lines of evidence, including our findings from both Drosophila and mouse models, support an RNA (fragile X premutation rCGG repeats)-mediated gain-of-function toxicity model for FXTAS, in which rCGG repeat-binding proteins (RBPs) become functionally limited through sequestration by lengthy rCGG repeats. Our previous work has identified two known RNA-binding proteins, Pur ? and hnRNP A2/B1, as RBPs. We showed that both proteins could modulate rCGG-mediated toxicity, supporting the RNA-mediated sequestration model of FXTAS. Using the translating ribosome affinity purification (TRAP) approach, we have also found that the expression of TDP-43 is significantly reduced in young mouse Purkinje neurons expressing rCGG repeats and that TDP-43 levels can modulate rCGG repeat-mediated toxicity in our FXTAS Drosophila model. Also unexpectedly we found that hnRNP A2/B1 can affect epigenetic modulation through interacting with Tet2, a member of Tet family proteins that converts 5- methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). In this proposal, we plan to continue to use both Drosophila and mouse models to further test the hypothesis that FXTAS results from abnormal RNA metabolism that stems from inappropriate association of RBPs with the RNA produced by FMR1 premutation alleles, and to explore the role of 5hmC-mediated epigenetic modulation in FXTAS pathogenesis. Successful completion of these studies should significantly advance our understanding the molecular pathogenesis of FXTAS. Identifications of genes and pathways involved in FXTAS will provide valuable targets for future pharmacological research aimed at developing drugs for therapy.

Public Health Relevance

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder that affects the carriers of premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. The long-term goal of this project is to understand the molecular pathogenesis of FXTAS, and develop effective therapeutic interventions for FXTAS. Here we will use both Drosophila and mouse models to test the hypothesis that FXTAS results from abnormal RNA metabolism that stems from inappropriate association of RBPs with the RNA produced by FMR1 premutation alleles.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS051630-09
Application #
8639182
Study Section
Cell Death and Injury in Neurodegeneration Study Section (CDIN)
Program Officer
Riddle, Robert D
Project Start
2005-04-01
Project End
2019-01-31
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
9
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Emory University
Department
Genetics
Type
Schools of Medicine
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Cheng, Ying; Wang, Zhi-Meng; Tan, Weiqi et al. (2018) Partial loss of psychiatric risk gene Mir137 in mice causes repetitive behavior and impairs sociability and learning via increased Pde10a. Nat Neurosci 21:1689-1703
Yao, Bing; Li, Yujing; Wang, Zhiqin et al. (2018) Active N6-Methyladenine Demethylation by DMAD Regulates Gene Expression by Coordinating with Polycomb Protein in Neurons. Mol Cell 71:848-857.e6
Cheng, Ying; Li, Ziyi; Manupipatpong, Sasicha et al. (2018) 5-Hydroxymethylcytosine alterations in the human postmortem brains of autism spectrum disorder. Hum Mol Genet 27:2955-2964
Yao, Bing; Jin, Peng (2018) A unique epigenomic landscape defines the characteristics and differentiation potentials of glioma stem cells. Genome Biol 19:51
Feng, Hao; Jin, Peng; Wu, Hao (2018) Disease prediction by cell-free DNA methylation. Brief Bioinform :
Sun, Xiaobo; Gao, Jingjing; Jin, Peng et al. (2018) Optimized distributed systems achieve significant performance improvement on sorted merging of massive VCF files. Gigascience 7:
Kim, Hyerim; Wang, Xudong; Jin, Peng (2018) Developing DNA methylation-based diagnostic biomarkers. J Genet Genomics 45:87-97
Yao, Bing; Cheng, Ying; Wang, Zhiqin et al. (2017) DNA N6-methyladenine is dynamically regulated in the mouse brain following environmental stress. Nat Commun 8:1122
Yoon, Ki-Jun; Ringeling, Francisca Rojas; Vissers, Caroline et al. (2017) Temporal Control of Mammalian Cortical Neurogenesis by m6A Methylation. Cell 171:877-889.e17
Li, Liping; Zang, Liqun; Zhang, Feiran et al. (2017) Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet 26:2398-2411

Showing the most recent 10 out of 76 publications